SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus

por Hurt, Christopher N, Nixon, Lisette S, Griffiths, Gareth O, Al-Mokhtar, Ruby, Gollins, Simon, Staffurth, John N, Phillips, Ceri J, Blazeby, Jane M, Crosby, Tom D
Publicado 2011